JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

Search

Veracyte Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

35.89 -4.78

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

35.6

Max

37.67

Pagrindiniai rodikliai

By Trading Economics

Pajamos

12M

19M

Pardavimai

1.7M

132M

P/E

Sektoriaus vid.

100.421

84.243

Pelno marža

14.512

Darbuotojai

824

EBITDA

4.4M

24M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+22.76% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-02-23

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

149M

3B

Ankstesnė atidarymo kaina

40.67

Ankstesnė uždarymo kaina

35.89

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bearish Evidence

Veracyte Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-04 22:55; UTC

Uždarbis

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

2026-02-04 21:44; UTC

Uždarbis

Arm Holdings 3Q Profit Falls Despite Revenue Growth

2026-02-04 21:39; UTC

Uždarbis

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

2026-02-04 23:46; UTC

Uždarbis

Arm Holdings Expects Slower Revenue Growth in 4Q -- Update

2026-02-04 23:46; UTC

Rinkos pokalbiai

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

2026-02-04 23:45; UTC

Karštos akcijos

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

2026-02-04 23:45; UTC

Uždarbis

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

2026-02-04 23:32; UTC

Rinkos pokalbiai

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

2026-02-04 22:59; UTC

Įsigijimai, susijungimai, perėmimai

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

2026-02-04 22:30; UTC

Uždarbis

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

2026-02-04 22:30; UTC

Uždarbis

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

2026-02-04 22:21; UTC

Uždarbis

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

2026-02-04 22:17; UTC

Rinkos pokalbiai

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

2026-02-04 22:15; UTC

Rinkos pokalbiai

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

2026-02-04 22:00; UTC

Rinkos pokalbiai

ESG Roundup: Market Talk

2026-02-04 21:53; UTC

Uždarbis

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

2026-02-04 21:51; UTC

Uždarbis

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

2026-02-04 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-02-04 21:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Financial Services Roundup: Market Talk

2026-02-04 21:50; UTC

Rinkos pokalbiai
Uždarbis

Auto & Transport Roundup: Market Talk

2026-02-04 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-02-04 21:45; UTC

Uždarbis

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

2026-02-04 21:44; UTC

Uždarbis

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

2026-02-04 21:43; UTC

Uždarbis

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

2026-02-04 21:41; UTC

Uždarbis

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

2026-02-04 21:36; UTC

Rinkos pokalbiai

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

2026-02-04 21:30; UTC

Uždarbis

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

2026-02-04 21:30; UTC

Uždarbis

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

2026-02-04 21:30; UTC

Uždarbis

Beach Energy Interim Dividend 1 Australian Cent/Sjare

2026-02-04 21:30; UTC

Uždarbis

Steris Sees FY Adj EPS $10.15-Adj EPS $10.30 >STE

Akcijų palyginimas

Kainos pokytis

Veracyte Inc Prognozė

Kainos tikslas

By TipRanks

22.76% į viršų

12 mėnesių prognozė

Vidutinis 46.33 USD  22.76%

Aukščiausias 50 USD

Žemiausias 43 USD

Remiantis 7 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Veracyte Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

7 ratings

5

Pirkti

1

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

30.5 / 31.38Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

335 / 352 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Veracyte Inc

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
help-icon Live chat